Cargando…
Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia
Our previous study demonstrated that phosphodiesterase 8 (PDE8) could work as a potential target for vascular dementia (VaD) using a chemical probe 3a. However, compound 3a is a chiral compound which was obtained by chiral resolution on HPLC, restricting its usage in clinic. Herein, a series of non-...
Autores principales: | Wu, Xu-Nian, Zhou, Qian, Huang, Ya-Dan, Xie, Xi, Li, Zhe, Wu, Yinuo, Luo, Hai-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293670/ https://www.ncbi.nlm.nih.gov/pubmed/35865094 http://dx.doi.org/10.1016/j.apsb.2022.02.012 |
Ejemplares similares
-
Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease
por: Zhang, Chen, et al.
Publicado: (2017) -
Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors
por: Wu, Xu-Nian, et al.
Publicado: (2018) -
Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease
por: Su, Tao, et al.
Publicado: (2016) -
Structure-Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel PDE10 Inhibitors With Antioxidant Activities
por: Li, Jinxuan, et al.
Publicado: (2018) -
Differential Expression and Function of PDE8 and PDE4 in Effector T cells: Implications for PDE8 as a Drug Target in Inflammation
por: Vang, Amanda G., et al.
Publicado: (2016)